Filing Details
- Accession Number:
- 0001127602-18-017910
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-17 16:43:34
- Reporting Period:
- 2018-05-15
- Accepted Time:
- 2018-05-17 16:43:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1083205 | U Richard Schutter De | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2018-05-15 | 15,000 | $21.83 | 133,383 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $21.56 to $22.05 per share.